Evidence map›Paper›PMID 36364144›Full record

ReviewMolecules (Basel, Switzerland)2022

The Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease.

Huixia Liu, Yujuan Li, Jing Xiong

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07162090 (Observation of the Impact of Hypoxia - Inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients), which is not on this map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07162090 phase4not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Observation of the Impact of Hypoxia - Inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients

TypeinterventionalSponsorTianjin Medical University General HospitalRan2025 to 2026Enrolled60ConditionsSarcopenia, Anemia Associated With Chronic Kidney Disease (CKD), Dialysis PatientsArmsRoxadustat, Recombinant human erythropoietin (EPO)
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Huixia LiuDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Yujuan LiDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Jing XiongDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Union Hospital · CNHuazhong University of Science and Technology · CN

Funding

National Natural Science Foundation of China 81770736
6 · The paper itself

Abstract

Partial pressure of oxygen (pO

Indexed as

Kidney NeoplasmsRenal Insufficiency, ChronicSarcopeniaHumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitOxygenHypoxia-Inducible Factor 1, alpha SubunitOxygencomplicationsdiabetic nephropathyhypoxia-inducible factor-1αrenal cancerrenal ischemia/reperfusion injury

Identifiers

PMID36364144
PMCPMC9657345
OpenAlexW4307940864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.